Independent wealth management firm London & Capital will begin offering a managed portfolio solution specifically for cell captives, a product it says will offer smaller players the kind of returns normally seen by their larger counterparts.
The new management solution integrates the services of an investment manager, custodian and insurance trustee together with independent portfolio valuation and reporting. According to the company, its new product offers cell captives higher targeted returns, a low-risk investment approach and access to a unique account subject to daily reporting in the name of greater transparency.
William Dalziel, a partner at London & Capital, said: “We can now also offer cells the type of portfolios and returns previously only available to larger players, ensuring their capital contributes to offsetting the cost of their insured risks. We are able to cater for cells with as little as $200,000 to invest, and deliver a service based upon the very same investment philosophy and asset allocation models as large captives enjoy.”
London & Capital, cell captives